Selected research
Industry Research
Animal Biotechnology Industry Research Report 2026
Market perspective
The global Animal Biotechnology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Animal Biotechnology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Animal Biotechnology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Animal Biotechnology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Animal Biotechnology include Biogenesis Bago, Boehringer Inghlem, Santa Cruz Biotechnology, Inc., Virbac Inc., Bayer AG, Pfizer, Inc., Merck &, Inc., Sanofi and Zoetis. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Animal Biotechnology market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Animal Biotechnology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Biotechnology Market by Company
Biogenesis Bago
Boehringer Inghlem
Santa Cruz Biotechnology, Inc.
Virbac Inc.
Bayer AG
Pfizer, Inc.
Merck &, Inc.
Sanofi
Zoetis
Animal Biotechnology Segment by Type
Diagnostic Tests
Vaccines
Drugs
Reporductive & Genetic Produtcs
Animal Biotechnology Segment by Application
Food Safety and Drug Development
Preventive Care for Animals
Development of Animal Pharmaceuticals
Others
Animal Biotechnology Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Biotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Animal Biotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostic Tests
- Vaccines
- Drugs
- Reporductive & Genetic Produtcs
Applications
- Food Safety and Drug Development
- Preventive Care for Animals
- Development of Animal Pharmaceuticals
- Others
Companies covered
- Biogenesis Bago
- Boehringer Inghlem
- Santa Cruz Biotechnology, Inc.
- Virbac Inc.
- Bayer AG
- Pfizer, Inc.
- Merck &, Inc.
- Sanofi
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Animal Biotechnology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diagnostic Tests
- 2.2.3 Vaccines
- 2.2.4 Drugs
- 2.2.5 Reporductive & Genetic Produtcs
- 2.3 Animal Biotechnology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Food Safety and Drug Development
- 2.3.3 Preventive Care for Animals
- 2.3.4 Development of Animal Pharmaceuticals
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Animal Biotechnology Breakdown Data by Type
- 3.1 Global Animal Biotechnology Historic Market Size by Type (2021-2026)
- 3.2 Global Animal Biotechnology Forecasted Market Size by Type (2027-2032)
4 Animal Biotechnology Breakdown Data by Application
- 4.1 Global Animal Biotechnology Historic Market Size by Application (2021-2026)
- 4.2 Global Animal Biotechnology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Animal Biotechnology Market Perspective (2021-2032)
- 5.2 Global Animal Biotechnology Growth Trends by Region
- 5.2.1 Global Animal Biotechnology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Animal Biotechnology Historic Market Size by Region (2021-2026)
- 5.2.3 Animal Biotechnology Forecasted Market Size by Region (2027-2032)
- 5.3 Animal Biotechnology Market Dynamics
- 5.3.1 Animal Biotechnology Industry Trends
- 5.3.2 Animal Biotechnology Market Drivers
- 5.3.3 Animal Biotechnology Market Challenges
- 5.3.4 Animal Biotechnology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Animal Biotechnology Players by Revenue
- 6.1.1 Global Top Animal Biotechnology Players by Revenue (2021-2026)
- 6.1.2 Global Animal Biotechnology Revenue Market Share by Players (2021-2026)
- 6.2 Global Animal Biotechnology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Animal Biotechnology Head Office and Area Served
- 6.4 Global Animal Biotechnology Players, Product Type & Application
- 6.5 Global Animal Biotechnology Manufacturers Established Date
- 6.6 Global Animal Biotechnology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Animal Biotechnology Market Size (2021-2032)
- 7.2 North America Animal Biotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Animal Biotechnology Market Size by Country (2021-2026)
- 7.4 North America Animal Biotechnology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Animal Biotechnology Market Size (2021-2032)
- 8.2 Europe Animal Biotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Animal Biotechnology Market Size by Country (2021-2026)
- 8.4 Europe Animal Biotechnology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Animal Biotechnology Market Size (2021-2032)
- 9.2 Asia-Pacific Animal Biotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Animal Biotechnology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Animal Biotechnology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Animal Biotechnology Market Size (2021-2032)
- 10.2 South America Animal Biotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Animal Biotechnology Market Size by Country (2021-2026)
- 10.4 South America Animal Biotechnology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Animal Biotechnology Market Size (2021-2032)
- 11.2 Middle East & Africa Animal Biotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Animal Biotechnology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Animal Biotechnology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Biogenesis Bago
- 12.1.1 Biogenesis Bago Company Information
- 12.1.2 Biogenesis Bago Business Overview
- 12.1.3 Biogenesis Bago Revenue in Animal Biotechnology Business (2021-2026)
- 12.1.4 Biogenesis Bago Animal Biotechnology Product Portfolio
- 12.1.5 Biogenesis Bago Recent Developments
- 12.2 Boehringer Inghlem
- 12.2.1 Boehringer Inghlem Company Information
- 12.2.2 Boehringer Inghlem Business Overview
- 12.2.3 Boehringer Inghlem Revenue in Animal Biotechnology Business (2021-2026)
- 12.2.4 Boehringer Inghlem Animal Biotechnology Product Portfolio
- 12.2.5 Boehringer Inghlem Recent Developments
- 12.3 Santa Cruz Biotechnology, Inc.
- 12.3.1 Santa Cruz Biotechnology, Inc. Company Information
- 12.3.2 Santa Cruz Biotechnology, Inc. Business Overview
- 12.3.3 Santa Cruz Biotechnology, Inc. Revenue in Animal Biotechnology Business (2021-2026)
- 12.3.4 Santa Cruz Biotechnology, Inc. Animal Biotechnology Product Portfolio
- 12.3.5 Santa Cruz Biotechnology, Inc. Recent Developments
- 12.4 Virbac Inc.
- 12.4.1 Virbac Inc. Company Information
- 12.4.2 Virbac Inc. Business Overview
- 12.4.3 Virbac Inc. Revenue in Animal Biotechnology Business (2021-2026)
- 12.4.4 Virbac Inc. Animal Biotechnology Product Portfolio
- 12.4.5 Virbac Inc. Recent Developments
- 12.5 Bayer AG
- 12.5.1 Bayer AG Company Information
- 12.5.2 Bayer AG Business Overview
- 12.5.3 Bayer AG Revenue in Animal Biotechnology Business (2021-2026)
- 12.5.4 Bayer AG Animal Biotechnology Product Portfolio
- 12.5.5 Bayer AG Recent Developments
- 12.6 Pfizer, Inc.
- 12.6.1 Pfizer, Inc. Company Information
- 12.6.2 Pfizer, Inc. Business Overview
- 12.6.3 Pfizer, Inc. Revenue in Animal Biotechnology Business (2021-2026)
- 12.6.4 Pfizer, Inc. Animal Biotechnology Product Portfolio
- 12.6.5 Pfizer, Inc. Recent Developments
- 12.7 Merck &, Inc.
- 12.7.1 Merck &, Inc. Company Information
- 12.7.2 Merck &, Inc. Business Overview
- 12.7.3 Merck &, Inc. Revenue in Animal Biotechnology Business (2021-2026)
- 12.7.4 Merck &, Inc. Animal Biotechnology Product Portfolio
- 12.7.5 Merck &, Inc. Recent Developments
- 12.8 Sanofi
- 12.8.1 Sanofi Company Information
- 12.8.2 Sanofi Business Overview
- 12.8.3 Sanofi Revenue in Animal Biotechnology Business (2021-2026)
- 12.8.4 Sanofi Animal Biotechnology Product Portfolio
- 12.8.5 Sanofi Recent Developments
- 12.9 Zoetis
- 12.9.1 Zoetis Company Information
- 12.9.2 Zoetis Business Overview
- 12.9.3 Zoetis Revenue in Animal Biotechnology Business (2021-2026)
- 12.9.4 Zoetis Animal Biotechnology Product Portfolio
- 12.9.5 Zoetis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst